SLCO1B1 and myopathy: In 2008, Link et al. found that a common nonsynonymous variant in the drug transporter SLCO1B1 (rs4149056) was associated with a 4-fold increase in the risk of myopathy among users of high dose simvastatin at genome-wide levels of statistical significance [4].